Company news

Cyclopharm Limited news in 2026

Cyclopharm Limited's news releases, calls and decks from 2026, newest first.

View company

Cyclopharm Q3 2026 Update

October 28, 2026

Cyclopharm Q3 2026 Update

October 28, 2026

Cyclopharm Q3 Investor Update Webinar

October 26, 2026

Retirement of Non-Executive Director Dianne Angus

October 25, 2026

Change in substantial shareholding for CYC

October 11, 2026

Chinese Consensus Names Technegas Preferred Lung Agent

October 6, 2026

Cyclopharm 1H 2026 Results Webinar

August 23, 2026

CYC 1H2026 Results Summary

August 23, 2026

Half Yearly Report and Accounts

August 23, 2026

New US Lung Imaging Guidelines Name Technegas as Preferred A

July 28, 2026

ausbiz TV Presentation

July 27, 2026

Immediate 11-Site Technegas Rollout at University Hospitals

July 14, 2026

CYC First-Half 2026 Update

July 1, 2026

USA Technegas Expansion Update

March 30, 2026

CYC Secures Multi-Site Agreement with Northwestern Medicine

March 23, 2026

CYC Signs Enterprise Agreement with UPHS

March 22, 2026

Preliminary Final Report

February 25, 2026

Technegas US Footprint Expanding Across Four Regions

February 19, 2026

Technegas Approved at the US National Institutes of Health

February 18, 2026

Cyclopharm Capital Raising Investor Presentation

February 3, 2026

Cyclopharm Successfully Completes A$14 million Placement

February 3, 2026

CYC Unaudited Trading Update - Preliminary FY2025 Results

February 1, 2026

Trading Halt

February 1, 2026

COPD Study Leveraging Technegas and AI-Driven Lung Analysis

January 28, 2026

Technegas Recognised in Updated Clinical Guideline

January 26, 2026

Insurer Indemnifies Cyclopharm

January 26, 2026

Stanford Children's Health to Implement Technegas

January 11, 2026

Decks in 2026